Jared Barsky

Array ( [id] => 7720878 [patent_doc_number] => 20120010213 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-12 [patent_title] => 'ORAL CONTROLLED RELEASE DOSAGE FORMS FOR WATER SOLUBLE DRUGS' [patent_app_type] => utility [patent_app_number] => 13/225984 [patent_app_country] => US [patent_app_date] => 2011-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4148 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20120010213.pdf [firstpage_image] =>[orig_patent_app_number] => 13225984 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8043427 [patent_doc_number] => 20120071451 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-22 [patent_title] => 'METHOD OF TREATING NONALCOHOLIC STEATOHEPATITIS WITH ELEVATED DOSES OF URSODEOXYCHOLIC ACID' [patent_app_type] => utility [patent_app_number] => 13/217042 [patent_app_country] => US [patent_app_date] => 2011-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5248 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0071/20120071451.pdf [firstpage_image] =>[orig_patent_app_number] => 13217042 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9034919 [patent_doc_number] => 20130237557 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-09-12 [patent_title] => 'TREATMENT' [patent_app_type] => utility [patent_app_number] => 13/816708 [patent_app_country] => US [patent_app_date] => 2011-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 10864 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13816708 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8940520 [patent_doc_number] => 20130190317 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-07-25 [patent_title] => 'COMBINATION OF COMPOUNDS FOR TREATING OR PREVENTING SKIN DISEASES' [patent_app_type] => utility [patent_app_number] => 13/821155 [patent_app_country] => US [patent_app_date] => 2011-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5519 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13821155 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7757107 [patent_doc_number] => 20120029036 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-02 [patent_title] => 'PHARMACEUTICAL COMPOSITIONS COMPRISING PYRIDYL CYANOGUANIDINE, PROCESS FOR PREPARING THE SAME AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 13/198633 [patent_app_country] => US [patent_app_date] => 2011-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13344 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20120029036.pdf [firstpage_image] =>[orig_patent_app_number] => 13198633 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8842072 [patent_doc_number] => 20130137700 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-30 [patent_title] => 'FUSED HETEROCYCLIC RING COMPOUND' [patent_app_type] => utility [patent_app_number] => 13/814035 [patent_app_country] => US [patent_app_date] => 2011-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30539 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13814035 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7568062 [patent_doc_number] => 20110288125 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-24 [patent_title] => 'NOVEL USE OF PIPERINE' [patent_app_type] => utility [patent_app_number] => 13/194582 [patent_app_country] => US [patent_app_date] => 2011-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5167 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0288/20110288125.pdf [firstpage_image] =>[orig_patent_app_number] => 13194582 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8638192 [patent_doc_number] => 20130029996 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-31 [patent_title] => 'SPECIAL COMPOSITION FOR THE USE THEREOF AS A DRUG' [patent_app_type] => utility [patent_app_number] => 13/574012 [patent_app_country] => US [patent_app_date] => 2011-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 4754 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13574012 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7587446 [patent_doc_number] => 20110281956 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-17 [patent_title] => 'USE OF THYMUS CAPITATUS EXTRACT, SATUREJA HORTENSIS EXTRACT, OR CARVACROL FOR TREATING METABOLIC DISEASES' [patent_app_type] => utility [patent_app_number] => 13/190020 [patent_app_country] => US [patent_app_date] => 2011-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8911 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20110281956.pdf [firstpage_image] =>[orig_patent_app_number] => 13190020 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7742455 [patent_doc_number] => 20120021050 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-26 [patent_title] => 'NANOPARTICLE FORMULATED GLYCOLIPID ANTIGENS FOR IMMUNOTHERAPY' [patent_app_type] => utility [patent_app_number] => 13/188642 [patent_app_country] => US [patent_app_date] => 2011-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 3219 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20120021050.pdf [firstpage_image] =>[orig_patent_app_number] => 13188642 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14609573 [patent_doc_number] => 10357464 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-07-23 [patent_title] => Methods for delivering volatile anesthetics for regional anesthesia and/or pain relief [patent_app_type] => utility [patent_app_number] => 13/183257 [patent_app_country] => US [patent_app_date] => 2011-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7089 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 124 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13183257 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7768073 [patent_doc_number] => 20120035204 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-09 [patent_title] => 'Methods for Treating Obesity and Disorders Associated with Hyperlipidemia in a Mammal' [patent_app_type] => utility [patent_app_number] => 13/182073 [patent_app_country] => US [patent_app_date] => 2011-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6485 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20120035204.pdf [firstpage_image] =>[orig_patent_app_number] => 13182073 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10128164 [patent_doc_number] => 09161985 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-10-20 [patent_title] => '5α-androstane (alkyl)-3β, 5, 6β-triol injection and preparation method therefor' [patent_app_type] => utility [patent_app_number] => 13/821849 [patent_app_country] => US [patent_app_date] => 2011-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2241 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13821849 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7712190 [patent_doc_number] => 20120004317 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-05 [patent_title] => 'Tapentadol for use in the treatment of irritable bowel syndrome' [patent_app_type] => utility [patent_app_number] => 13/172103 [patent_app_country] => US [patent_app_date] => 2011-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5314 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13172103 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7670136 [patent_doc_number] => 20110319405 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-29 [patent_title] => 'Treatment and prevention of diffuse parenchymal lung disease by selective active-site mTOR inhibitors' [patent_app_type] => utility [patent_app_number] => 13/171441 [patent_app_country] => US [patent_app_date] => 2011-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 22188 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13171441 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7663775 [patent_doc_number] => 20110313044 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-22 [patent_title] => 'Polymorphs of Suberoylanilide Hydroxamic Acid' [patent_app_type] => utility [patent_app_number] => 13/161763 [patent_app_country] => US [patent_app_date] => 2011-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 6259 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0313/20110313044.pdf [firstpage_image] =>[orig_patent_app_number] => 13161763 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8830021 [patent_doc_number] => 20130131066 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-23 [patent_title] => 'TREATMENT OF TYPE 1 DIABETES' [patent_app_type] => utility [patent_app_number] => 13/703147 [patent_app_country] => US [patent_app_date] => 2011-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5717 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13703147 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8916877 [patent_doc_number] => 20130178503 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-07-11 [patent_title] => 'METHODS OF TREATING HEMATOLOGIC MALIGNANCIES USING 6-CYCLOHEXYL-1-HYDROXY-4-METHYL-2(1H)-PYRIDONE' [patent_app_type] => utility [patent_app_number] => 13/701486 [patent_app_country] => US [patent_app_date] => 2011-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 20189 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13701486 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7651925 [patent_doc_number] => 20110301194 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-08 [patent_title] => 'Method for Determining Treatment Efficacy' [patent_app_type] => utility [patent_app_number] => 13/150295 [patent_app_country] => US [patent_app_date] => 2011-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 21385 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0301/20110301194.pdf [firstpage_image] =>[orig_patent_app_number] => 13150295 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9831909 [patent_doc_number] => 08940725 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-01-27 [patent_title] => 'Purinone derivative' [patent_app_type] => utility [patent_app_number] => 13/700774 [patent_app_country] => US [patent_app_date] => 2011-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25009 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13700774 [rel_patent_id] =>[rel_patent_doc_number] =>)